investors
With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.
We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.
- Johan Spetz
- CFO and Head of Investor Relations
- ir@sedanamedical.com
The Share
Press Releases
2026
2026-03-13 08:00
Sedana Medical AB (publ) today reports that the first patient has been treated in the company’s Early Access Program (EAP) in the U.S. The program...
2026-02-12 07:00
Positive EBITDA in our ex-US business Fourth quarter 2025 January-December 2025 CEO comments Positive EBITDA in our ex-US business 2025 marked a successful...
2026-01-29 08:00
Sedana Medical AB (publ) plans to present its interim report for the fourth quarter of 2025 on Thursday February 12 at 13:30 CET. According to the financial...

